XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Infectious Diseases Channel
subscribe to Infectious Diseases newsletter

Latest Research : Infectious Diseases

   DISCUSS   |   EMAIL   |   PRINT
Whooping Cough Vaccine Now For Adults
Oct 25, 2005, 21:15, Reviewed by: Dr.

"It's a misconception that you're protected from pertussis for life if you've been vaccinated as a child. The study demonstrated that an estimated one in 300 adolescents and adults contracts the illness each year. The results also demonstrate that an effective vaccine is now available for this population and its use should be strongly encouraged."

 
In the first study of its kind, researchers at Saint Louis University have demonstrated that immunization with a new vaccine could potentially prevent more than a million cases of pertussis (whooping cough) each year in adolescents and adults.

Most children are protected from pertussis by a series of vaccines in early childhood. But the vaccine protection wanes after a decade or so, leaving adolescents and adults susceptible to the bacterial infection.

"It's a misconception that you're protected from pertussis for life if you've been vaccinated as a child," said Stephen J. Barenkamp, M.D., professor of pediatrics and one of the study's clinical investigators. He also is director of the Pediatric Research Institute at the Saint Louis University School of Medicine. "The study demonstrated that an estimated one in 300 adolescents and adults contracts the illness each year. The results also demonstrate that an effective vaccine is now available for this population and its use should be strongly encouraged."

Barenkamp's comments are based on results of a large, multi-center clinical study of more than 2,781 healthy adolescents and adults between the ages of 15 and 65. Barenkamp said approximately half the patients received a vaccine to protect against pertussis. The other half received a control vaccine. Researchers followed the patients for 2.5 years and determined that the pertussis vaccine was more than 90 percent effective in preventing the highly contagious illness.

Although pertussis is rarely life-threatening in adults, Barenkamp said the booster shot would not only prevent weeks of severe coughing, it hopefully would also prevent adults from spreading the infection to small children, for whom the disease can be deadly.

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recently recommended that all 11 and 12 year olds be given a dose of this new pertussis vaccine as a combined formulation with tetanus and diphtheria boosters. Recommendations for immunization of older adults are under active review.

Barenkamp said another purpose of the study was to gather data on the true incidence of pertussis in adolescents and adults. He said that underreporting of the illness is substantial because physicians often do not consider the possibility of pertussis when they treat adults for persistent cough. Complicating matters further, he said, the test used to detect pertussis in children is often not sensitive enough to detect pertussis in adults. Barenkamp said a test used during the study known as the pertussis polymerase chain reaction (PCR) assay is more sensitive and is becoming more widely available for testing of patients of all ages.
 

- Study results were published in the October 13, 2005 issue of the New England Journal of Medicine.
 

www.slu.edu

 
Subscribe to Infectious Diseases Newsletter
E-mail Address:

 

Other institutions that participated in the study include: the UCLA Center for Vaccine Research; University of Rochester; University of Pittsburgh School of Medicine; Children's Hospital of Pittsburgh; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; University of Maryland School of Medicine; Vanderbilt University Medical Center; and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research, and provides health services on a local, national and international level.


Related Infectious Diseases News

Keeping A3G in action represents a new way to attack HIV
Fighting HIV With HIV Virus Itself
Retina can provide a very reliable way of diagnosing cerebral malaria
Are influenza vaccines worth the effort?
A light daily exercise program may reduce the incidence of colds
HIV exploits competition among T-cells
Mass vaccination would not be necessary in the event of a smallpox bioterrorist attack
How Ebola and Marburg viruses cause disease
Transmission of MRSA Linked to Previous Intensive Care Unit Room Occupants
Harmless GB Virus type C (GBV-C) protects against HIV infection


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us